N

Novellia

AI-enabled platform centralizing personal health data

Overview

Novellia builds a free health data platform in the United States that aggregates patient records from thousands of healthcare systems into a single, secure, continuously updated profile, including doctors’ notes, test results, and insurance claims. It connects to providers via APIs and uses a rules engine to normalize and deduplicate data, creating a complete, longitudinal view with patient consent. Beyond data consolidation, it offers personalized educational content and matches users to suitable clinical trials, while not charging patients. Revenue comes from licensing anonymized, aggregated real-world data to life sciences and biopharma companies to support research and precision medicine, differentiating itself through patient-authorized data, a longitudinal data resource, and a data-licensing model.

Significant Headcount Growth

Work here?Claim your company

About Novellia

Simplify's Rating
Why Novellia is rated
C+
Rated B on Competitive Edge
Rated B on Growth Potential
Rated D+ on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareAI & Machine LearningHealthcare

Company Size

11-50

Company Stage

Series A

Total Funding

$18M

Headquarters

New York City, New York

Founded

2023

Get referred to Novellia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Novellia launched its patient-facing mobile app on June 2, 2026, widening consumer reach.
  • Customers include several top-10 pharmaceutical companies and early-stage diagnostics firms.
  • Fierce Pharma’s April 14, 2026 award boosted credibility with drug-development buyers.

What critics are saying

  • SAGER v. Novellia, filed April 21, 2026 in Pennsylvania, signals active commercial dispute.
  • HIPAA and deidentification scrutiny can freeze patient enrollment and block pharma procurement quickly.
  • If regulators restrict patient-authorized data sharing, Novellia’s core licensing model collapses.

What makes Novellia unique

  • Novellia’s patient-authorized dataset spans 20+ years across providers, payers, and care settings.
  • The July 23, 2026 GLP-1 registry includes 6,000+ patients and longitudinal treatment changes.
  • Spark Capital’s June 2, 2026 Series A validated seven-figure, multiyear pharma demand.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$18M

Above

Industry Average

Funded Over

1 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Above Average

Industry standards

$15M
$8.2M
$15M
$18M
$30M

Benefits

  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Flexible Time off
  • Wellness stipend
  • Parental Leave
  • Medical, dental, and vision coverage
  • Equity in Novellia

Growth & Insights and Company News

Headcount

6 month growth

32%

1 year growth

23%

2 year growth

42%
PR Newswire
Sep 24th, 2026
Novellia named one of Crain's New York Business' 2026 Best Places to Work in NYC.

Novellia named one of Crain's New York Business' 2026 Best Places to Work in NYC. Sep 24, 2026, 15:03 ET The Recognition, Determined in Large Part by Employee Surveys, Follows a Milestone Year of Growth and Industry Honors NEW YORK, Sept. 24, 2026 /PRNewswire/ - Novellia, the patient data company that unifies a person's clinical histories across every system, practice, and provider they've used, today announced it has been named one of Crain's New York Business' 2026 Best Places to Work in New York City. This honor highlights Novellia's commitment to an employee-driven culture where curiosity, collaboration, and relentless innovation come together to give patients power over their own health journey. "I've watched people on this team turn a stranger's worst day into relief, and I still find that remarkable no matter how many times I see it happen," said Shashi Shankar, co-founder and CEO of Novellia. "My co-founder Eli and I built this culture the same way we built our product. We put the patient at the center of every decision. I believe that is why this team continues outdoing itself. I am honored to work alongside them, and I hope every person who joins Novellia next feels the same pride in this team that I feel today." The Best Places to Work in New York City program recognizes companies across the city based on comprehensive independent evaluations of workplace culture, employee experience, policies, benefits, and organizational values. The list is compiled in partnership with Best Companies Group, and employee survey feedback accounts for the majority of each company's score. Over the past year, Novellia has grown its team by 240%, reflecting the company's rapid growth following its $18 million Series A. This momentum is driven by our growing community, which has now surpassed 100 million patient records. This milestone brings us closer to our goal of giving every individual a complete, easily accessible view of their own health journey. Novellia has also been recognized as a 2026 Fierce Outsourcing Award recipient for Innovation in Drug Development and a 2026 MedTech Breakthrough Award winner for Best Healthcare Data Repository Solution. As the company continues to expand, it is looking for mission-driven people who want to help patients take control of their health data and accelerate research. To learn more about open roles at Novellia, please visit novellia.com/careers. About Novellia Novellia, Inc. is a patient data company that helps people find and unify over 20 years of health data in seconds so they can get better care, while accelerating medical breakthroughs by partnering with patients to help researchers get the most complete view of the patient journey. Named one of Digital Health New York's 10 startups to watch, a 2026 Fierce Outsourcing Award recipient for Innovation in Drug Development, and a 2026 MedTech Breakthrough Award winner for Best Healthcare Data Repository Solution, Novellia is the only real-world data company built entirely on information patients choose to share with research. Novellia is backed by peer-reviewed research presented at medical congresses, including ASCO, NORD, APHA, IMPACCT, and SABCS. To learn more, visit www.novellia.com. SOURCE Novellia

PR Newswire
Jul 23rd, 2026
Novellia launches GLP-1 patient registry with 20+ years of longitudinal data to address real-world treatment gaps

Novellia has launched its GLP-1 and Metabolic Health Registry to provide healthcare organisations with comprehensive real-world data on GLP-1 therapies. The registry draws from over 6,000 patients' clinical records, unified across every provider, payer and care setting, with each record spanning more than 20 years of continuous medical history. Early insights reveal that 81% of high-comorbidity patients achieved at least 5% weight loss, compared to 54% of low-comorbidity patients. Over 75% of enrolled patients carry high comorbidity burdens, including anxiety, depression and chronic pain. The New York-based company aims to address gaps in traditional clinical trials and claims data, which often lag behind patient care and underrepresent patients with multiple comorbidities. The registry continues to expand daily, providing visibility into treatment changes, coverage disruptions and real-world factors affecting patient outcomes.

PR Newswire
Jun 2nd, 2026
Novellia Secures $18M Series A to Scale Patient-Powered Data Platform, Solving Pharma's $50B Problem

/PRNewswire/ -- Novellia, the only real-world data company built entirely on information patients choose to contribute to medical research, today announced an...

SiliconANGLE Media
Jun 2nd, 2026
Novellia raises $18M to scale patient-controlled medical data platform.

Novellia raises $18M to scale patient-controlled medical data platform. Patient-controlled health data startup Novellia Inc. today announced it has raised $18 million in Series A funding to scale up a platform that lets patients consolidate their medical records and choose to share them with drug companies for research. The company also announced the launch of a patient-facing mobile app. Novellia operates what it calls the only real-world data company built entirely on information patients elect to contribute, positioning itself against third-party data brokers that assemble research datasets from insurance claims and hospital records. It says the current model leaves the patient out of the equation despite a market that runs above $50 billion a year. Novellia's platform pulls together as much as 20 years of medical history from disparate hospital systems, doctors' offices and labs across the U.S. in under 30 seconds. The company says the tool is particularly aimed at people managing serious or complex conditions, who typically spend hours chasing down records and repeating their histories to new providers. Once records are consolidated, Novellia applies natural language processing models to extract structured signals from unstructured clinical text, including physician notes, lab narratives and diagnostic reports. The company says that material is often the richest layer of a medical record and the hardest for existing data vendors to access. The output is de-identified into datasets that pharmaceutical companies use for research. Novellia counts several of the top 10 pharmaceutical companies and a number of early-stage diagnostics firms among its customers. According to the company, it has signed seven-figure, multiyear contracts with some of the largest drugmakers in the world since the Series A closed. "Behind every patient is a fragmented, incomplete record of their life," said co-founder and Chief Executive Shashi Shankar. "I watched this up close: first through my grandfather's cancer journey and then professionally in pharma, where we were developing therapies without ever seeing the full picture." The newly launched mobile app extends Novellia's existing web platform, giving individuals a free way to access and organize their full health history from a phone. The company has cited research showing close to 70% of patients are willing to contribute data for medical research if they are given control, transparency and privacy protections. The Series A was led by Spark Capital, with participation from Khosla Ventures, Acrew Capital, Bling Capital and TMV. "For a long time, I looked for a company like Novellia," said Alex Finkelstein, general partner at Spark Capital. "Shashi understood the problem firsthand and built the solution that benefits patients and research." Novellia is based in New York. The new round takes its total funding to $28 million. Image: Novellia. A message from John Furrier, co-founder of SiliconANGLE: Support its mission to keep content open and free by engaging with theCUBE community. Join theCUBE's Alumni Trust Network, where technology leaders connect, share intelligence and create opportunities. * 15M+ viewers of theCUBE videos, powering conversations across AI, cloud, cybersecurity and more * 11.4k+ theCUBE alumni - Connect with more than 11,400 tech and business leaders shaping the future through a unique trusted-based network. About SiliconANGLE Media SiliconANGLE Media is a recognized leader in digital media innovation, uniting breakthrough technology, strategic insights and real-time audience engagement. As the parent company of SiliconANGLE, theCUBE Network, theCUBE Research, CUBE365, theCUBE AI and theCUBE SuperStudios - with flagship locations in Silicon Valley and the New York Stock Exchange - SiliconANGLE Media operates at the intersection of media, technology and AI. Founded by tech visionaries John Furrier and Dave Vellante, SiliconANGLE Media has built a dynamic ecosystem of industry-leading digital media brands that reach 15+ million elite tech professionals. Its new proprietary theCUBE AI Video Cloud is breaking ground in audience interaction, leveraging theCUBEai.com neural network to help technology companies make data-driven decisions and stay at the forefront of industry conversations.

Axios
Jun 2nd, 2026
Novellia raises $18M for pharma real-world data

Investors still see opportunities in a space that crowded with incumbents.

Recently Posted Jobs

Sign up to get curated job recommendations

Novellia is Hiring for 5 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs